Author： Amouyel Philippe
Publisher： Future Medicine
ISSN： 1462-2416
Source： Pharmacogenomics, Vol.3, Iss.1, 2002-01, pp. : 1-3
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
Pharmacogenomics of neurodegenerative diseases
By Maimone D. Dominici R. Grimaldi L.M.E.
European Journal of Pharmacology, Vol. 413, Iss. 1, 2001-02 ,pp. :
Access to resources
Recommend
Sirtuins as Possible Targets in Neurodegenerative Diseases
Current Drug Targets, Vol. 14, Iss. 6, 2013-06 ,pp. :
Pharmacogenetics and pharmacogenomics
By Daly Ann K
Pharmacogenomics, Vol. 8, Iss. 11, 2007-11 ,pp. :
From pharmacogenetics to pharmacogenomics
By Lackner K.J.
Trends in Pharmacological Sciences, Vol. 23, Iss. 1, 2002-01 ,pp. :
Systems approaches for pharmacogenetics and pharmacogenomics
By Bader Joel S
Pharmacogenomics, Vol. 9, Iss. 3, 2008-03 ,pp. :